3 winners awarded for making significant contributions in research for rare cancer known as cholangiocarcinoma
The Cholangiocarcinoma Foundation announced the 2022 Poster Abstract Awards at its annual conference that took place virtually and in-person in downtown Salt Lake City. The award winners were honored for making significant contributions with a visual overview of cholangiocarcinoma research to increase knowledge and advance treatment. through their posters. The Foundation is pleased to announce the poster awards to Queralt Serra Camprubí, PhD, Edward Jarman, PhD, and Niranjan Awasthi, PhD.
The Foundation is a leading global resource for cholangiocarcinoma, a rare cancer of the bile ducts. The conference continues to be a premier source for the presentation of cutting-edge research, innovative therapies, and patient education in the field of cholangiocarcinoma and is a highlight for all who attend. More than 1,600 people participated in the 2021 annual conference including 800 patients and caregivers, 300 clinicians and researchers, and 400 industry representatives and sponsors hailing from 49 states and 44 countries.
“Drs. Camprubí, Jarman, and Awasthi have demonstrated an unwavering commitment to the cholangiocarcinoma community. We are grateful to them for their dedication to the study of this difficult-to-treat disease. It is my honor to present the 2022 Poster Awards to these outstanding individuals,” said Stacie Lindsey, Foundation CEO and founder.
The Foundation offers an opportunity for professionals in industry and medical fields consistent with the organization’s mission “to support patients and render cholangiocarcinoma a treatable disease,” to present a poster each year at the conference. Posters are intended to provide authors and conference participants with the opportunity to connect with one another and build upon the foundation of knowledge exchange and collaboration.
This year, the Foundation had 40 abstracts submitted with nine selected for oral poster presentations. All posters were reviewed by the Abstract Review Committee Chaired by Jesper Andersen, PhD of the University of Copenhagen, and Lipika Goyal, MD, MPhil of
Massachusetts General Hospital Cancer Center Hospital. Three posters were selected for recognition awards:
The Special Collaboration Prize was awarded to Queralt Serra Camprubí, Vall Hebron Institute of Oncology, Barcelona, Spain for her abstract titled, “Human metastatic cholangiocarcinoma (CCA)-patient-derived xenografts and tumoroids for cancer studies and drug screenings.”
The Special Abstract Prize is awarded to Edward Jarman, University of Edinburgh in the UK for his abstract titled, “Identifying the earliest molecular events at the interface between liver regeneration and tumor initiation in iCCA.”
The 2nd Special Abstract Prize poster is awarded to Niranjan Awasthi, for his abstract titled, “Inhibition of serotonin biosynthesis by telotristat ethyl augments chemotherapy effects in cholangiocarcinoma.”
“Drs. Camprubí, Jarman, and Awasthi have demonstrated an unwavering commitment to the cholangiocarcinoma community. We are grateful to them for their dedication to the study of this difficult-to-treat disease. It is my honor to present the 2022 Poster Awards to these outstanding individuals.”
Foundation CEO, and founder